Biolase, Inc. (BIOL): Price and Financial Metrics
BIOL Price/Volume Stats
| Current price | $0.15 | 52-week high | $32.09 |
| Prev. close | $0.14 | 52-week low | $0.13 |
| Day low | $0.15 | Volume | 22,681 |
| Day high | $0.15 | Avg. volume | 4,491,315 |
| 50-day MA | $0.15 | Dividend yield | N/A |
| 200-day MA | $2.02 | Market Cap | 4.79M |
BIOL Stock Price Chart Interactive Chart >
Biolase, Inc. (BIOL) Company Bio
BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company was founded in 1984 and is based in Irvine, California.
Latest BIOL News From Around the Web
Below are the latest news stories about BIOLASE INC that investors may wish to consider to help them evaluate BIOL as an investment opportunity.
BIOLASE RECEIVES TOP WORKPLACES 2023 AWARDBIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been awarded a Top Workplaces 2023 honor by Orange County Register Top Workplaces. The award is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage LLC. The confidential survey uniquely measures 15 culture drivers that are critical to success, including alignment, execution, and connection. |
BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser TrialBIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the successful completion of a trial program featuring the Waterlase iPlus All Tissue laser conducted by six leading U.S. dentists. The trial, led by an independent consultant, evaluated both the potential return on investment (ROI) and clinical adoption of BIOLASE's leading technology. The trial revealed unanimous doctor satisfaction with the performance and desire to recommend the purchase to others. This represe |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! |
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesBIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $1.4 million of its common stock and pre-funded warrants in a registered direct offering and warrants to purchase common stock in a concurrent private placement, priced at-the-market under Nasdaq rules. The combined effective purchase price for one share of common stock (or pre-funded warrant in l |
BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIESBIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023. |
BIOL Price Returns
| 1-mo | -6.43% |
| 3-mo | -83.14% |
| 6-mo | -91.02% |
| 1-year | -99.29% |
| 3-year | -99.99% |
| 5-year | -100.00% |
| YTD | -86.63% |
| 2023 | -98.27% |
| 2022 | -93.33% |
| 2021 | -6.41% |
| 2020 | -24.61% |
| 2019 | -44.17% |
Continue Researching BIOL
Want to see what other sources are saying about Biolase Inc's financials and stock price? Try the links below:Biolase Inc (BIOL) Stock Price | Nasdaq
Biolase Inc (BIOL) Stock Quote, History and News - Yahoo Finance
Biolase Inc (BIOL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...